Shuttle Pharmaceutical Holdings has reached an agreement to acquire United Dogecoin Inc. in a strategic merger complemented by an $11 million investment through a PIPE (Private Investment in Public Equity) financing. This groundbreaking move aims to create a publicly traded enterprise focused on mining Dogecoin, one of the most talked-about cryptocurrencies.
As part of the arrangement, United Dogecoin is set to deploy 3,000 ElphaPex mining rigs within 60 days following the completion of the merger. These advanced rigs are anticipated to produce a total hash rate of 43,200 GH/s, which would account for approximately 1.5% of the global Dogecoin mining capacity. This swift installation is part of a broader strategy to seize a prominent position in the Dogecoin mining sector as institutional investments begin to flow into the market.
Shuttle, which is primarily known for its AI pharmaceuticals platform, indicated that the public listing will enable United Dogecoin to acquire the necessary capital to scale its operations significantly, surpassing what current private mining ventures have achieved in the Dogecoin arena. United Dogecoin envisions employing a dual strategy similar to successful Bitcoin mining operations—actively mining Dogecoin while also holding it as an asset on its balance sheet.
Ryan Trasolini, CEO of United Dogecoin, expressed optimism about the merger’s potential. He stated, “The completion of this transaction will give investors exposure to Dogecoin via our dual-pronged strategy of mining Dogecoin with highly efficient, cost-effective rigs and holding mined Dogecoin on our balance sheet to build long-term asset value.” Trasolini will co-lead the newly formed entity alongside Shuttle’s leadership.
Board member Andrew Kiguel noted that United Dogecoin’s approach bears similarities to Hut 8’s strategies in the early days of Bitcoin mining. “We believe that while the opportunity for incredible upside in new Bitcoin miners has passed, Dogecoin mining is in its infancy, and United Dogecoin is well-positioned to be a leader in the space,” he said.
Following the announcement, Shuttle Pharmaceutical Holdings (SHPH) experienced a significant rise in its stock price, climbing from a closing price of $1.03 to an after-hours high of $1.52. However, the stock has since retraced most of those gains, trading around $1.05. Meanwhile, Dogecoin has recently seen a surge, gaining approximately 12% over the past week, making it the top performer among the leading ten cryptocurrencies by market capitalization. It was trading just below $0.11 after briefly reaching a two-month high earlier in the day.
The merger marks a pivotal moment for both companies as they look to capitalize on the burgeoning market for Dogecoin mining amidst increasing institutional interest.
